Law360, New York (March 18, 2011, 6:23 PM EDT) -- Generic-drug maker SigmaPharm Inc. on Friday appealed a Pennsylvania federal judge's dismissal of its antitrust and contract suit against Mutual Pharmaceutical Co. Inc. and King Pharmaceuticals Inc. over royalties for a potential generic version of muscle relaxant Skelaxin.
A notice of appeal was filed in the U.S. District Court for the Eastern District of Pennsylvania, a couple of weeks after Judge Cynthia M. Rufe threw out SigmaPharm's suit. The case is being appealed to the U.S. Court of Appeals for the Third Circuit.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.